Performance improvement of a drag hydrokinetic turbine

Hydropower is at present in many locations, among all the other possible renewable energy sources, the best one for net cost per unit power. In contrast to traditional installation, based on water storage in artificial basins, free flow river turbines also provide a very low environmental impact due to their negligible effect on solid transport. Among them, kinetic turbines with vertical axis are very inexpensive and have almost zero impact on fish and local fauna. In application to tidal waves and sea waves, where vertically averaged velocities have alternate direction, a Savonius rotor also has the advantage of being productive during the whole time cycle. In this work, the effect of an upstream deflector system mounted upstream of a twisted Savonius rotor inside a channel has been investigated through numerical simulations and experimental tests. Numerical simulations were carried on using the ANSYS FLUENT 17.0 software. Based on this numerical study, it is shown that the proposed deflector system has improved the power coefficient of the Savonius rotor by 14%. The utilization of this new design system is predicted to contribute towards a more efficient use of flows in rivers and channels for electricity production in rural areas

Results of combined treatment of anaplastic thyroid carcinoma (ATC)

<p>Abstract</p> <p>Background</p> <p>Anaplastic thyroid carcinoma (ATC) is among the most aggressive human malignancies. It is associated with a high rate of local recurrence and with poor prognosis.</p> <p>Methods</p> <p>We retrospectively reviewed 44 consecutive patients treated between 1996 and 2010 at Leon Berard Cancer Centre, Lyon, France. The combined treatment strategy derived from the one developed at the Institut Gustave Roussy included total thyroidectomy and cervical lymph-node dissection, when feasible, combined with 2 cycles of doxorubicin (60 mg/m2) and cisplatin (100 mg/m2) Q3W, hyperfractionated (1.2 Gy twice daily) radiation to the neck and upper mediastinum (46-50 Gy), and then four cycles of doxorubicin-cisplatin.</p> <p>Results</p> <p>Thirty-five patients received the three-phase combined treatment. Complete response after treatment was achieved in 14/44 patients (31.8%). Eight patients had a partial response (18.2%). Twenty-two (50%) had progressive disease. All patients with metastases at diagnosis died shortly afterwards. Thirteen patients are still alive. The median survival of the entire population was 8 months.</p> <p>Conclusion</p> <p>Despite the ultimately dismal prognosis of ATC, multimodality treatment significantly improves local control and appears to afford long-term survival in some patients. There is active ongoing research, and results obtained with new targeted systemic treatment appear encouraging.</p